Abstract
The use of a new strain of Bacillus thuringiensis has been successfully used in mosquito control in Israel. Toxicity tests with Culex pipiens and Aedes aegypti showed that the strain was effective in LD50 bioassays. Field trials with B. thuringiensis showed that several applications were needed and the organism shows promise to replace currently used insecticides.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Saliternik, Z., 1964. Malaria and its control in Israel. Hacohen Press. Jerusalem, 183 pp.
Goldberg, L. and Margalit, J., 1977. Bacterial spore demonstrating rapid larvicidae activity against Anopheles sergentii, Uronutaenia unguiculata, Culex univittatus, Aedes aegypti, and Culex pipiens . Mosquito News 37: 355–358.
de Barjac, H., 1978. Une nouvelle variete de Bacillus thuringiensis tres toxique pour le moustique: B. thuringiensis var. israelensis serotype 14. C.R. Acad. Sci. (Paris), 2860: 797–800.
WHO VBC Document, 1982. Data sheet on the biological control agent: Bacillus thuringiensis var. israelensis Serotype H14 (de Barjac, 1978). WHO mimeographed document WHO/VBC/79. 750 Rev. 1.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Margalit, J., Zomer, E., Erel, Z. et al. Development and Application of Bacillus Thuringiensis Var. Israelensis Serotype H 14 as an Effective Biological Control Agent Against Mosquitoes in Israel. Nat Biotechnol 1, 74–76 (1983). https://doi.org/10.1038/nbt0383-74
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0383-74